US11957649B2ActiveUtilityA1

Methods and pharmaceutical preparations for elevating ketone utilization

Assignee: GLYKON TECH GROUP LLCPriority: Jun 2, 2020Filed: May 25, 2021Granted: Apr 16, 2024
Est. expiryJun 2, 2040(~13.9 yrs left)· nominal 20-yr term from priority
A61K 31/194A61P 3/00A61P 25/16A61P 25/28A61K 36/38
68
PatentIndex Score
0
Cited by
8
References
6
Claims

Abstract

The invention relates generally to the field of medical treatment. More particularly, the invention relates to treating a patient in order to increase the amount of ketones metabolized by mitochondria. Exemplary patients include those with Alzheimer's disease and insulin resistance.

Claims

exact text as granted — not AI-modified
That which is claimed is: 
     
       1. A method of improving a subject's performance on an academic task, comprising:
 administering HCA to the subject to increase the subject's metabolism of triglycerides into ketones, wherein HCA is (-)-hydroxycitric acid, a salt thereof, or a derivative thereof; and 
 performing the academic task between 10 minutes and 600 minutes after the administration, wherein the increased metabolism of triglycerides into ketones improves performance on the academic task. 
 
     
     
       2. The method of  claim 1 , wherein administered HCA corresponds to 500 mg to 10,000 mg of (—)-hydroxycitric acid. 
     
     
       3. The method of  claim 1 , further comprising hypothesizing or determining that the subject's performance on the task would improve if mitochondria of the subject metabolized more ketones, wherein the hypothesizing or determining is performed before the administration. 
     
     
       4. The method of  claim 1 , wherein the academic task is academic studying. 
     
     
       5. The method of  claim 1 , wherein the academic task is completing an academic assignment. 
     
     
       6. The method of  claim 1 , wherein the academic task is taking an academic test.

Join the waitlist — get patent alerts

Track US11957649B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.